找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Diagnostic and Therapeutic Antibodies; Andrew J. T. George,Catherine E. Urch Book 2000 Humana Press 2000

[复制链接]
查看: 29551|回复: 60
发表于 2025-3-21 17:37:42 | 显示全部楼层 |阅读模式
书目名称Diagnostic and Therapeutic Antibodies
编辑Andrew J. T. George,Catherine E. Urch
视频video
概述Includes supplementary material:
丛书名称Methods in Molecular Medicine
图书封面Titlebook: Diagnostic and Therapeutic Antibodies;  Andrew J. T. George,Catherine E. Urch Book 2000 Humana Press 2000
描述Soon after the first description of monoclonal antibodies in 1976, there was enormous interest in the clinical application of antibodies, especially in the context of cancer. Antibodies appeared to offer the “magic bullet” that would allow the specific destruction of neoplastic cells. H- ever, many years’ effort resulted in very few cases of successful immu- therapy with antibodies. As a result there was a major backlash against antibody therapy, and the field lost a considerable amount of popularity. Fashion, in science as well as in other things, tends to be cyclical. Antibody-based therapy is once again attracting scientists and clinicians. There are several reasons for the renewed optimism; certainly the expe- ence of the last two decades has provided a wealth of information about problems associated with antibody therapy, and possible solutions to these problems. Recombinant antibody engineering has rejuvenated the field, allowing both the modification of antibodies to improve their in vivo pr- erties and the isolation of novel antibody molecules by such techniques as phage display. The results of recent clinical trials have demonstrated unequivocally the benefit of antibody t
出版日期Book 2000
版次1
doihttps://doi.org/10.1385/1592590764
isbn_softcover978-1-61737-195-0
isbn_ebook978-1-59259-076-6Series ISSN 1543-1894 Series E-ISSN 1940-6037
issn_series 1543-1894
copyrightHumana Press 2000
The information of publication is updating

书目名称Diagnostic and Therapeutic Antibodies影响因子(影响力)




书目名称Diagnostic and Therapeutic Antibodies影响因子(影响力)学科排名




书目名称Diagnostic and Therapeutic Antibodies网络公开度




书目名称Diagnostic and Therapeutic Antibodies网络公开度学科排名




书目名称Diagnostic and Therapeutic Antibodies被引频次




书目名称Diagnostic and Therapeutic Antibodies被引频次学科排名




书目名称Diagnostic and Therapeutic Antibodies年度引用




书目名称Diagnostic and Therapeutic Antibodies年度引用学科排名




书目名称Diagnostic and Therapeutic Antibodies读者反馈




书目名称Diagnostic and Therapeutic Antibodies读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:17:49 | 显示全部楼层
Polyclonal and Monoclonal Antibodies unlimited supply of a single antibody that is clearly defined and of reproducible specificity and affinity is of greater value. To produce such a reagent it is necessary to isolate and culture a single clone of B lymphocytes secreting antibody of the appropriate characteristics-that is, to produce
发表于 2025-3-22 00:46:28 | 显示全部楼层
发表于 2025-3-22 05:44:22 | 显示全部楼层
发表于 2025-3-22 09:42:43 | 显示全部楼层
Antibody-Based Therapies in Infectious Diseasesccesses with immune serum were observed in treatment and prevention of other infectious diseases, which include . meningitis, measles, diphtheria, hepatitis A and B, poliovirus infection, and cytomegalovirus (CMV) infection (.). However, numerous problems have been observed with immune sera, includi
发表于 2025-3-22 13:17:13 | 显示全部楼层
Antibodies for Immunoassayshormones, peptides, e.g., vasopressin, proteins, e.g., cytokines, as well as carbohydrate structures, e.g., CA-125. Immunoassay technology has developed to such an extent that it is probably the most versatile analytical tool available able to identify and quantify epitopic structures across the mil
发表于 2025-3-22 20:01:10 | 显示全部楼层
发表于 2025-3-23 01:03:30 | 显示全部楼层
发表于 2025-3-23 05:28:04 | 显示全部楼层
发表于 2025-3-23 06:35:38 | 显示全部楼层
B. Müller,A. Marek,H.-Th. Jankapersonal communication) have recently achieved more than 70% complete responses in posttransplant lymphoma treated with a chimeric anti-CD20 mAb, and Maloney and co-workers (.) recently reported a 50% response rate in relapsed, low-grade, NHL, with a 10---11 mo duration. Encouragingly, patients in t
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-5 23:58
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表